 | • レポートコード：D0GIR-02579 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、mRNA癌ワクチン及び治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。mRNA癌ワクチン及び治療の種類別市場規模（標準化がん治療用MRNAワクチン、個別化がん治療MRNAワクチン、感染症治療MRNAワクチン、感染症予防MRNAワクチン）、用途別市場規模（感染症、がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Moderna Therapeutics、eTheRNA、BioNTech、CureVac、In-Cell-Art、Translate Bio、Tiba Biotechnology、Argos Therapeutics、Sangamo Therapeutics、Ethris ・地域別グローバル市場分析 2015年-2020年 ・mRNA癌ワクチン及び治療の北米市場（アメリカ、カナダ、メキシコ） ・mRNA癌ワクチン及び治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・mRNA癌ワクチン及び治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・mRNA癌ワクチン及び治療の南米市場（ブラジル、アルゼンチン） ・mRNA癌ワクチン及び治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：標準化がん治療用MRNAワクチン、個別化がん治療MRNAワクチン、感染症治療MRNAワクチン、感染症予防MRNAワクチン ・用途別分析：感染症、がん、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The mRNA Cancer Vaccines and Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global mRNA Cancer Vaccines and Therapeutics sales will be xx in 2020 from mRNA Cancer Vaccines and Therapeutics million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global mRNA Cancer Vaccines and Therapeutics market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the mRNA Cancer Vaccines and Therapeutics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on mRNA Cancer Vaccines and Therapeutics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
mRNA Cancer Vaccines and Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, mRNA Cancer Vaccines and Therapeutics market has been segmented into:
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By Application, mRNA Cancer Vaccines and Therapeutics has been segmented into:
Infectious Disease
Cancer
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global mRNA Cancer Vaccines and Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level mRNA Cancer Vaccines and Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global mRNA Cancer Vaccines and Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the mRNA Cancer Vaccines and Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and mRNA Cancer Vaccines and Therapeutics Market Share Analysis
mRNA Cancer Vaccines and Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, mRNA Cancer Vaccines and Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the mRNA Cancer Vaccines and Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in mRNA Cancer Vaccines and Therapeutics are:
Moderna Therapeutics
eTheRNA
BioNTech
CureVac
In-Cell-Art
Translate Bio
Tiba Biotechnology
Argos Therapeutics
Sangamo Therapeutics
Ethris
Among other players domestic and global, mRNA Cancer Vaccines and Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 mRNA Cancer Vaccines and Therapeutics Market Overview
1.1 Product Overview and Scope of mRNA Cancer Vaccines and Therapeutics
1.2 Classification of mRNA Cancer Vaccines and Therapeutics by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type in 2019
1.2.3 Standardization Of Cancer Treatment MRNA Vaccine
1.2.4 Individualized Cancer Treatment MRNA Vaccine
1.2.5 Infectious Disease Treatment MRNA Vaccine
1.2.6 Infection Prevention MRNA Vaccine
1.3 Global mRNA Cancer Vaccines and Therapeutics Market by Application
1.3.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Global mRNA Cancer Vaccines and Therapeutics Market by Regions
1.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of mRNA Cancer Vaccines and Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) mRNA Cancer Vaccines and Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) mRNA Cancer Vaccines and Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) mRNA Cancer Vaccines and Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) mRNA Cancer Vaccines and Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) mRNA Cancer Vaccines and Therapeutics Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: mRNA Cancer Vaccines and Therapeutics Industry Impact
1.5.1 COVID-19 Potential Implications for the mRNA Cancer Vaccines and Therapeutics
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on mRNA Cancer Vaccines and Therapeutics
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Moderna Therapeutics SWOT Analysis
2.1.4 Moderna Therapeutics Product and Services
2.1.5 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 eTheRNA
2.2.1 eTheRNA Details
2.2.2 eTheRNA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 eTheRNA SWOT Analysis
2.2.4 eTheRNA Product and Services
2.2.5 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioNTech
2.3.1 BioNTech Details
2.3.2 BioNTech Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BioNTech SWOT Analysis
2.3.4 BioNTech Product and Services
2.3.5 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 CureVac
2.4.1 CureVac Details
2.4.2 CureVac Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CureVac SWOT Analysis
2.4.4 CureVac Product and Services
2.4.5 CureVac mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 In-Cell-Art
2.5.1 In-Cell-Art Details
2.5.2 In-Cell-Art Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 In-Cell-Art SWOT Analysis
2.5.4 In-Cell-Art Product and Services
2.5.5 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Translate Bio
2.6.1 Translate Bio Details
2.6.2 Translate Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Translate Bio SWOT Analysis
2.6.4 Translate Bio Product and Services
2.6.5 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Tiba Biotechnology
2.7.1 Tiba Biotechnology Details
2.7.2 Tiba Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Tiba Biotechnology SWOT Analysis
2.7.4 Tiba Biotechnology Product and Services
2.7.5 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Argos Therapeutics
2.8.1 Argos Therapeutics Details
2.8.2 Argos Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Argos Therapeutics SWOT Analysis
2.8.4 Argos Therapeutics Product and Services
2.8.5 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sangamo Therapeutics
2.9.1 Sangamo Therapeutics Details
2.9.2 Sangamo Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sangamo Therapeutics SWOT Analysis
2.9.4 Sangamo Therapeutics Product and Services
2.9.5 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ethris
2.10.1 Ethris Details
2.10.2 Ethris Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Ethris SWOT Analysis
2.10.4 Ethris Product and Services
2.10.5 Ethris mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 mRNA Cancer Vaccines and Therapeutics Players Market Share
3.2.2 Top 10 mRNA Cancer Vaccines and Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Regions
4.2 North America mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
5 North America mRNA Cancer Vaccines and Therapeutics Revenue by Countries
5.1 North America mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2015-2020)
5.2 USA mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe mRNA Cancer Vaccines and Therapeutics Revenue by Countries
6.1 Europe mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2015-2020)
6.2 Germany mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue by Countries
7.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2015-2020)
7.2 China mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
8 South America mRNA Cancer Vaccines and Therapeutics Revenue by Countries
8.1 South America mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue mRNA Cancer Vaccines and Therapeutics by Countries
9.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Type (2019-2024)
10.3 Standardization Of Cancer Treatment MRNA Vaccine Revenue Growth Rate (2015-2025)
10.4 Individualized Cancer Treatment MRNA Vaccine Revenue Growth Rate (2015-2025)
10.5 Infectious Disease Treatment MRNA Vaccine Revenue Growth Rate (2015-2025)
10.6 Infection Prevention MRNA Vaccine Revenue Growth Rate (2015-2025)
11 Global mRNA Cancer Vaccines and Therapeutics Market Segment by Application
11.1 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2015-2020)
11.2 mRNA Cancer Vaccines and Therapeutics Market Forecast by Application (2019-2024)
11.3 Infectious Disease Revenue Growth (2015-2020)
11.4 Cancer Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast (2021-2025)
12.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast (2021-2025)
12.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America mRNA Cancer Vaccines and Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe mRNA Cancer Vaccines and Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America mRNA Cancer Vaccines and Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global mRNA Cancer Vaccines and Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of mRNA Cancer Vaccines and Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global mRNA Cancer Vaccines and Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global mRNA Cancer Vaccines and Therapeutics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Moderna Therapeutics Corporate Information, Location and Competitors
Table 7. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Major Business
Table 8. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 9. Moderna Therapeutics SWOT Analysis
Table 10. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 11. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. eTheRNA Corporate Information, Location and Competitors
Table 13. eTheRNA mRNA Cancer Vaccines and Therapeutics Major Business
Table 14. eTheRNA mRNA Cancer Vaccines and Therapeutics Total Revenue (USD Million) (2018-2019)
Table 15. eTheRNA SWOT Analysis
Table 16. eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 17. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. BioNTech Corporate Information, Location and Competitors
Table 19. BioNTech mRNA Cancer Vaccines and Therapeutics Major Business
Table 20. BioNTech mRNA Cancer Vaccines and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 21. BioNTech SWOT Analysis
Table 22. BioNTech mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 23. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. CureVac Corporate Information, Location and Competitors
Table 25. CureVac mRNA Cancer Vaccines and Therapeutics Major Business
Table 26. CureVac mRNA Cancer Vaccines and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 27. CureVac SWOT Analysis
Table 28. CureVac mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 29. CureVac mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. In-Cell-Art Corporate Information, Location and Competitors
Table 31. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Major Business
Table 32. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 33. In-Cell-Art SWOT Analysis
Table 34. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 35. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Translate Bio Corporate Information, Location and Competitors
Table 37. Translate Bio mRNA Cancer Vaccines and Therapeutics Major Business
Table 38. Translate Bio mRNA Cancer Vaccines and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 39. Translate Bio SWOT Analysis
Table 40. Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 41. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Tiba Biotechnology Corporate Information, Location and Competitors
Table 43. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Major Business
Table 44. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 45. Tiba Biotechnology SWOT Analysis
Table 46. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 47. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Argos Therapeutics Corporate Information, Location and Competitors
Table 49. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Major Business
Table 50. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 51. Argos Therapeutics SWOT Analysis
Table 52. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 53. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Sangamo Therapeutics Corporate Information, Location and Competitors
Table 55. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Major Business
Table 56. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 57. Sangamo Therapeutics SWOT Analysis
Table 58. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 59. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Ethris Corporate Information, Location and Competitors
Table 61. Ethris mRNA Cancer Vaccines and Therapeutics Major Business
Table 62. Ethris mRNA Cancer Vaccines and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 63. Ethris SWOT Analysis
Table 64. Ethris mRNA Cancer Vaccines and Therapeutics Product and Solutions
Table 65. Ethris mRNA Cancer Vaccines and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 67. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Players (2015-2020)
Table 68. Global mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 69. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Regions (2015-2020)
Table 70. North America mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2015-2020)
Table 71. North America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries (2015-2020)
Table 72. Europe mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 74. South America mRNA Cancer Vaccines and Therapeutics Revenue by Countries (2015-2020)
Table 75. South America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries (2015-2020)
Table 78. Global mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 79. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Type (2015-2020)
Table 80. Global mRNA Cancer Vaccines and Therapeutics Revenue Forecast by Type (2021-2025)
Table 81. Global mRNA Cancer Vaccines and Therapeutics Revenue by Application (2015-2020)
Table 82. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Application (2015-2020)
Table 83. Global mRNA Cancer Vaccines and Therapeutics Revenue Forecast by Application (2021-2025)
Table 84. Global mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. mRNA Cancer Vaccines and Therapeutics Picture
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type in 2019
Figure 3. Standardization Of Cancer Treatment MRNA Vaccine Picture
Figure 4. Individualized Cancer Treatment MRNA Vaccine Picture
Figure 5. Infectious Disease Treatment MRNA Vaccine Picture
Figure 6. Infection Prevention MRNA Vaccine Picture
Figure 7. mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application in 2019
Figure 8. Infectious Disease Picture
Figure 9. Cancer Picture
Figure 10. Other Picture
Figure 11. Global mRNA Cancer Vaccines and Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players mRNA Cancer Vaccines and Therapeutics Revenue Market Share in 2019
Figure 20. Global Top 10 Players mRNA Cancer Vaccines and Therapeutics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 24. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Regions in 2018
Figure 25. North America mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Europe mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. South America mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. North America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 31. North America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2019
Figure 32. USA mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Canada mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Europe mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2019
Figure 37. Germany mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. UK mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. France mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Russia mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Italy mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2019
Figure 44. China mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Japan mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Korea mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. India mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. South America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 50. South America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2019
Figure 51. Brazil mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. UAE mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa mRNA Cancer Vaccines and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Type (2015-2020)
Figure 60. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Type in 2019
Figure 61. Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Type (2021-2025)
Figure 62. Global Standardization Of Cancer Treatment MRNA Vaccine Revenue Growth Rate (2015-2020)
Figure 63. Global Individualized Cancer Treatment MRNA Vaccine Revenue Growth Rate (2015-2020)
Figure 64. Global Infectious Disease Treatment MRNA Vaccine Revenue Growth Rate (2015-2020)
Figure 65. Global Infection Prevention MRNA Vaccine Revenue Growth Rate (2015-2020)
Figure 66. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Application (2015-2020)
Figure 67. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Application in 2019
Figure 68. Global mRNA Cancer Vaccines and Therapeutics Market Share Forecast by Application (2021-2025)
Figure 69. Global Infectious Disease Revenue Growth Rate (2015-2020)
Figure 70. Global Cancer Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global mRNA Cancer Vaccines and Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America mRNA Cancer Vaccines and Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Europe mRNA Cancer Vaccines and Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. South America mRNA Cancer Vaccines and Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
mRNAワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…- mRNA療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 癌ワクチン薬剤パイプラインの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Vaccines Drug Pipeline market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Vaccines…
- 膀胱癌治療・診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bladder Cancer Therapeutics and Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 551.5 million by 2025, from USD 427.6 million in 2019…
- 膵臓がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Pancreatic Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pancreatic Can…